Crossmark

Impact of osteoporosis liaison services on the expected lifetime osteoporosis-related medical expenses of patients with fragility fracture in a private hospital in Japan

Crossref DOI link: https://doi.org/10.1007/s11657-022-01101-0

Published Online: 2022-04-13

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kobayashi, Saori

Tanaka, Shinya

Yoshino, Yasumasa

Tobita, Hideki

Kuwagaki, Kanae

Fujioka, Rie

Totsuka, Hiroaki

Ichiba, Yuka

Ishimine, Sachiko

Sakamoto, Kazumi

Ohama, Hikaru

Kubo, Toshiro
License Information

Text and Data Mining valid from 2022-04-13

Version of Record valid from 2022-04-13
More Information

Article History

Received: 6 August 2021

Accepted: 18 March 2022

First Online: 13 April 2022

Declarations

:

: Yasumasa Yoshino has received speaker honorariums from Asahi Kasei Pharma Corporation, Taisyo Pharmaceutical Holdings, Pfizer Japan Inc., and Eli Lilly Japan K.K. Shinya Tanaka has received speaker honorariums from Teijin Pharma Ltd., Asahi Kasei Pharma Corporation, Astellas Pharma Inc., Amgen Inc., Taisyo Pharmaceutical Holdings, and Eisai Co., Ltd.

Document is current

Any future updates will be listed below